For the Inventor, By the Inventor

Enter assignee name

Beaverton, OR, United States of America

Viscardia, Inc.

USPTO Granted Patents = 21

EPO Patents = 5

Trademarks = 3

Forward Citations = 164

Loading Chart...

Loading Chart...

6 inventors (with patents filed for the assignee):

Peter T Bauer (21 out of 35 patents)

Edward Chinchoy (8 out of 8 patents)

Jay Snell (8 out of 15 patents)

4. Timothy K Wheeler (5 out of 8 patents)

5. Patricia A Arand (2 out of 23 patents)

6. Gregg Harris (1 out of 1 patent)

21 patents: Sort by Forward Citations

1. 12364859 - Systems, devices, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation (2025-07-22),

2. 12357825 - Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (2025-07-15),

3. 12144993 - Hemodynamic performance enhancement through asymptomatic diaphragm stimulation (2024-11-19),

4. 11957914 - Implantable medical systems, devices and methods for delivering asymptomatic diaphragmatic stimulation (2024-04-16),

5. 11925803 - Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (2024-03-12),

6. 11911616 - Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (2024-02-27),

7. 11684783 - Hemodynamic performance enhancement through asymptomatic diaphragm stimulation (2023-06-27),

8. 11666757 - Systems, devices, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation (2023-06-06),

9. 11524158 - Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (2022-12-13),

10. 11458312 - Implantable medical systems, devices, and methods for affecting cardiac function through diaphragm stimulation, and for monitoring diaphragmatic health (2022-10-04),

11. 11400286 - Implantable medical devices, systems, and methods for selection of optimal diaphragmatic stimulation parameters to affect pressures within the intrathoracic cavity (2022-08-02),

12. 11147968 - Systems, devices, and methods for improving hemodynamic performance through asymptomatic diaphragm stimulation (2021-10-19),

13. 11020596 - Hemodynamic performance enhancement through asymptomatic diaphragm stimulation (2021-06-01),

14. 10537735 - Implantable medical devices and methods for real-time or near real-time adjustment of diaphragmatic stimulation parameters to affect pressures within the intrathoracic cavity (2020-01-21),

15. 10493271 - Implantable medical devices, systems, and methods for selection of optimal diaphragmatic stimulation parameters to affect pressures within the intrathoracic cavity (2019-12-03),

Company Overview

Viscardia, Inc. is a technology company based in Beaverton, Oregon, specializing in advanced medical devices aimed at improving cardiac health. The organization focuses on developing innovative solutions that enhance patient care and outcomes through cutting-edge research in biomedical engineering. With a commitment to addressing critical challenges in cardiovascular treatment, Viscardia leverages its expertise to create products that integrate seamlessly into clinical practices, ultimately striving to advance the field of cardiology.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

21 Patents

#21 in Beaverton, OR

#163 in Oregon

#15,681 in US

#29,928 in the World

Beaverton, OR, United States of America

Viscardia, Inc.

Forward Citations = 164

6 inventors:

Peter T Bauer (21 out of 35 patents)

Edward Chinchoy (8 out of 8 patents)

Jay Snell (8 out of 15 patents)

4. Timothy K Wheeler (5 out of 8 patents)

5. Patricia A Arand (2 out of 23 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Viscardia, Inc.. Retrieved from https://idiyas.com/company/viscardia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…